hederagenin has been researched along with Diabetic Glomerulosclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, H; Ma, W; Yang, G; Yang, W; Yi, Q | 1 |
1 other study(ies) available for hederagenin and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Hederagenin inhibits high glucose-induced fibrosis in human renal cells by suppression of NLRP3 inflammasome activation through reducing cathepsin B expression.
Topics: Cathepsin B; Diabetic Nephropathies; Fibrosis; Glucose; Humans; Inflammasomes; NLR Family, Pyrin Domain-Containing 3 Protein; RNA, Messenger | 2023 |